X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
female (11) 11
index medicus (11) 11
male (10) 10
aged (9) 9
middle aged (9) 9
adult (5) 5
analysis (4) 4
double-blind method (4) 4
rheumatology (4) 4
aged, 80 and over (3) 3
article (3) 3
care and treatment (3) 3
complications (3) 3
depression (3) 3
drug therapy (3) 3
health aspects (3) 3
lipids (3) 3
medical colleges (3) 3
obesity (3) 3
osteoporosis (3) 3
polymers (3) 3
psychiatry (3) 3
risk (3) 3
abridged index medicus (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
antirheumatic agents - therapeutic use (2) 2
anxiety (2) 2
cancer-patients (2) 2
cardiac & cardiovascular systems (2) 2
cardiovascular diseases (2) 2
case-control studies (2) 2
citalopram - therapeutic use (2) 2
clinical trials (2) 2
comorbidity (2) 2
complications and side effects (2) 2
coronary angiography (2) 2
corticosteroids (2) 2
depression, mental (2) 2
diabetes (2) 2
diabetes mellitus (2) 2
diabetes mellitus - epidemiology (2) 2
diabetes therapy (2) 2
diet (2) 2
dose-response relationship, drug (2) 2
drosophila (2) 2
drugs (2) 2
gene (2) 2
gene expression (2) 2
giant cell arteritis (2) 2
giant cell arteritis - drug therapy (2) 2
glaucoma (2) 2
glaucoma - epidemiology (2) 2
glucocorticoids - adverse effects (2) 2
glucose (2) 2
health services research (2) 2
homeostasis (2) 2
il-6 (2) 2
inadequate response (2) 2
incidence (2) 2
infections (2) 2
insects (2) 2
insulin (2) 2
insulin resistance (2) 2
interleukin-6 receptor inhibition (2) 2
liver (2) 2
materials science, multidisciplinary (2) 2
medical research (2) 2
medicine, research & experimental (2) 2
melanoma (2) 2
melanoma - drug therapy (2) 2
metabolism (2) 2
mood (2) 2
mortality (2) 2
nanoscience & nanotechnology (2) 2
neurosciences (2) 2
osteoporosis - epidemiology (2) 2
outcomes research (2) 2
patients (2) 2
performance (2) 2
physics, applied (2) 2
placebo-controlled trial (2) 2
poly (2) 2
polymyalgia-rheumatica (2) 2
prednisolone - adverse effects (2) 2
retrospective studies (2) 2
risk factors (2) 2
science (2) 2
serious adverse events (2) 2
serotonin reuptake inhibitors (2) 2
temporal arteritis (2) 2
treatment outcome (2) 2
type 2 diabetes (2) 2
united-kingdom (2) 2
abuse (1) 1
academic degrees (1) 1
accreditation (1) 1
acquired immunodeficiency syndrome - complications (1) 1
acquired immunodeficiency syndrome - epidemiology (1) 1
acquired immunodeficiency syndrome - mortality (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2017, Volume 46, Issue 6, pp. 819 - 827
Journal Article
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 09/2013, Volume 38, Issue 10, pp. 1921 - 1928
wInterleukin (IL)-2, a T-cell cytokine used to treat malignant melanoma, can induce profound depression. To determine whether pretreatment with the... 
escitalopram | melanoma | adrenocorticotropin (ACTH) | interleukin-2 | depression | interleukin-6 | ACTIVATION | PSYCHIATRY | INTERLEUKIN-2 TREATMENT | IL-2 | NEUROSCIENCES | PATHOPHYSIOLOGY | INTERFERON-ALPHA | CANCER-PATIENTS | GENE-EXPRESSION | VASOPRESSIN | PHARMACOLOGY & PHARMACY | RECEPTORS | Melanoma - blood | Citalopram - pharmacology | Interleukin-2 - adverse effects | Humans | Middle Aged | Interleukin-2 - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Interleukin-2 - antagonists & inhibitors | Depression - drug therapy | Antineoplastic Agents - adverse effects | Interleukin-2 - administration & dosage | Interleukin-6 - blood | Depression - chemically induced | Adult | Female | Antidepressive Agents - pharmacology | Antineoplastic Agents - pharmacology | Drug Therapy, Combination | Hydrocortisone - blood | Adrenocorticotropic Hormone - blood | Melanoma - metabolism | Antineoplastic Agents - antagonists & inhibitors | Double-Blind Method | Treatment Outcome | Antidepressive Agents - therapeutic use | Medication Adherence | Citalopram - administration & dosage | Melanoma - immunology | Melanoma - drug therapy | Interleukin-2 - pharmacology | Antidepressive Agents - administration & dosage | Citalopram - therapeutic use | Aged | Melanoma - psychology | biological psychiatry | neuroendocrinology | mood | stress disorders | anxiety | adrenocorticotropin | clinical pharmacology | clinical trials | Original
Journal Article
by Almasi, Gheorghe and Asaad, Sameh and Bellofatto, Ralph E and Bickford, H. Randall and Blumrich, Matthias A and Brezzo, Bernard and Bright, Arthur A and Brunheroto, Jose R and Castanos, Jose G and Chen, Dong and Chiu, George L.-T and Coteus, Paul W and Dombrowa, Marc B and Dozsa, Gabor and Eichenberger, Alexandre E and Gara, Alan and Giampapa, Mark E and Giordano, Frank P and Gunnels, John A and Hall, Shawn A and Haring, Ruud A and Heidelberger, Philip and Hoenicke, Dirk and Kochte, Michael and Kopcsay, Gerard V and Kumar, Sameer and Lanzetta, Alphonso P and Lieber, Derek and Nathanson, Ben J and O'Brien, Kathryn and Ohmacht, Alda S and Ohmacht, Martin and Rand, Rick A and Salapura, Valentina and Sexton, James C and Steinmacher-Burow, Burkhard D and Stunkel, Craig and Sugavanam, Krishnan and Swetz, Richard A and Takken, Todd and Tian, Shurong and Trager, Barry M and Tremaine, Robert B and Vranas, Pavlos and Walkup, Robert E and Wazlowski, Michael E and Winograd, Shmuel and Wisniewski, Robert W and Wu, Peng and Busche, Dennis R and Douskey, Steven M and Ellavsky, Matthew R and Flynn, William T and Germann, Philip R and Hamilton, Michael J and Hehenberger, Lance and Hruby, Brian J and Jeanson, Mark J and Kasemkhani, Fariba and Lembach, Robert F and Liebsch, Thomas A and Lyndgaard, Kelly C and Lytle, Robert W and Marcella, James A and Marroquin, Christopher M and Mathiowetz, Curt H and Maurice, Michael D and Nelson, Eldon and Rickert, Dennis M and Sellers, Glenn W and Sheets, John E and Strissel, Scott A and Wait, Charles D and Winter, Bruce B and Wood, Cory J and Zumbrunnen, Laura M and Rangarajan, Meera and Allen, Paul V and Archer, Charles J and Blocksome, Michael and Budnik, Thomas A and Ellis, Sam D and Good, Michael P and Gooding, Thomas M and Inglett, Todd A and Kaliszewski, Kerry T and Knudson, Brant L and Lappi, Cory and Leckband, Glenn S and Lee, Susan and Megerian, Mark G and Miller, Samuel J and Mundy, Michael B and Musselman, Roy G and Musta, Thomas E and Nelson, Michael T and Obert, Carl F and Van Oosten, James L and Orbeck, John P and Parker, Jeffrey J and ... and IBM Blue Gene Team
IBM Journal of Research and Development, ISSN 0018-8646, 2008, Volume 52, Issue 1-2, pp. 199 - 220
On June 26, 2007, IBM announced the Blue Gene/P (TM) system as the leading offering in its massively parallel Blue Geneo supercomputer line, succeeding the... 
COMPUTER SCIENCE, SOFTWARE ENGINEERING | COMPUTER SCIENCE, INFORMATION SYSTEMS | COMPUTER SCIENCE, HARDWARE & ARCHITECTURE | COMPUTER SCIENCE, THEORY & METHODS | Product introduction | Computer industry | Supercomputers | Product design | Processing speed | High performance systems | Computer architecture
Journal Article
Journal Article
Clinical Trials, ISSN 1740-7745, 10/2009, Volume 6, Issue 5, pp. 480 - 490
Journal Article
Biological Psychiatry, ISSN 0006-3223, 2005, Volume 58, Issue 3, pp. 175 - 189
The purpose of this review is to assess the relationship between mood disorders and development, course, and associated morbidity and mortality of selected... 
Mood disorders | medical comorbidity | depression | antidepressant therapy | Depression | Antidepressant therapy | Medical comorbidity | PSYCHIATRY | mood disorders | HIV-INFECTED MEN | ISCHEMIC-HEART-DISEASE | HUMAN-IMMUNODEFICIENCY-VIRUS | NEUROSCIENCES | SEROTONIN REUPTAKE INHIBITORS | DOUBLE-BLIND PLACEBO | METASTATIC BREAST-CANCER | ACUTE MYOCARDIAL-INFARCTION | PLACEBO-CONTROLLED TRIAL | PITUITARY-ADRENAL AXIS | CORONARY-ARTERY-DISEASE | Mood Disorders - therapy | Prevalence | Humans | Brain Diseases - mortality | Acquired Immunodeficiency Syndrome - therapy | Diabetes Complications - therapy | Mood Disorders - epidemiology | Mood Disorders - etiology | Neoplasms - complications | Osteoporosis | Neoplasms - therapy | Pain | Brain Diseases - therapy | Cerebrovascular Disorders - complications | Diabetes Complications - epidemiology | Cerebrovascular Disorders - epidemiology | Obesity | Brain Diseases - epidemiology | Comorbidity | Diabetes Complications - metabolism | Neoplasms - mortality | Cerebrovascular Disorders - therapy | Diabetes Complications - complications | Cerebrovascular Disorders - mortality | Delivery of Health Care - standards | Brain Diseases - complications | Acquired Immunodeficiency Syndrome - epidemiology | Acquired Immunodeficiency Syndrome - mortality | Mood Disorders - mortality | Acquired Immunodeficiency Syndrome - complications | Neoplasms - epidemiology | Practice Guidelines as Topic | Medical colleges | Care and treatment | Antidepressants | Depression, Mental | Bipolar disorder | Health aspects | Cancer
Journal Article